CARDIOVASCULAR RISK
Clinical trials for CARDIOVASCULAR RISK explained in plain language.
Never miss a new study
Get alerted when new CARDIOVASCULAR RISK trials appear
Sign up with your email to follow new studies for CARDIOVASCULAR RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New monthly shot aims to stop second heart attacks
Disease control Recruiting nowThis study tests a new monthly injection called ziltivekimab in 10,000 people who recently had a heart attack. The goal is to see if it can lower the risk of having another heart attack, a stroke, or dying from heart disease. Participants will receive either the study drug or a p…
Matched conditions: CARDIOVASCULAR RISK
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a phone app help lower your cholesterol? new study aims to find out
Disease control Recruiting nowThis study tests a digital health program called Corrie Lipids in about 1,000 adults with high LDL cholesterol and heart disease risk. The program includes a smartphone app for tracking cholesterol, medication reminders, and education, plus training for doctors to improve cholest…
Matched conditions: CARDIOVASCULAR RISK
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New study eyes hidden diabetes damage in cystic fibrosis patients
Knowledge-focused Recruiting nowThis study looks at how often people with cystic fibrosis and diabetes develop complications like eye, kidney, and nerve problems. Researchers will also check blood pressure and cholesterol. The goal is to better understand these risks in a diverse group of 200 adolescents and ad…
Matched conditions: CARDIOVASCULAR RISK
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
30,000 italians join study to revolutionize heart disease prediction
Knowledge-focused Recruiting nowThis study is testing whether adding genetic and imaging information to standard risk assessments can better predict heart disease in 30,000 healthy Italian adults aged 40-80. Participants will have their risk calculated using traditional methods and then again with the added dat…
Matched conditions: CARDIOVASCULAR RISK
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC